TDP-43, a heterogeneous nuclear ribonucleoprotein, was identified as a component of ubiquitin-positive and tau-negative inclusions observed in cases of frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS). Immunochemical analyses using antibodies generated against phospho- and non-phosphopeptides of human TDP-43 revealed that abnormally phosphorylated full-length TDP-43 (45 kDa), C-terminal fragments (~25 kDa) and smearing substances are deposited as intracellular inclusions in affected regions of FTLD-U and ALS cases. These antibodies are powerful tools for biochemical and immunohistochemical analyses of neurodegenerative diseases and for evaluation of cellular or animal models of TDP-43 proteinopathy.
Product Specifications
Application
ELISA, IHC, WB
Reactivity
Rat, Human
Clonality
Polyclonal
Host
Rabbit
Documents & Links for Anti TAR DNA-binding protein 43 (TDP-43) Amino Acids 3-12 pAb (Rabbit, Antiserum)
Citations for Anti TAR DNA-binding protein 43 (TDP-43) Amino Acids 3-12 pAb (Rabbit, Antiserum) – 1 Found
Kawahara, Yukio; Mieda-Sato, Ai. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proceedings Of The National Academy Of Sciences Of The United States Of America. 2012;109(9):3347-52. PubMed